Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Bullboard Posts
Post by HCallahann44on Jan 21, 2020 1:39pm
195 Views
Post# 30578633

So what is the bear case here...there must be one...

So what is the bear case here...there must be one...or we wouldn't see the stock gyrating the way it does. Everything looks so promising..PR product being poked and probed by a lot of big pharma...big pharma announcing it wants to acquire companies exactly like ONCY...low number of outstanding shares...lots of catalysts...comparable companies getting taken out at multiples of todays price....preliminary results of PR product looking good...first mover...solid management...decent analyst coverage. So what is the downside...will studies show that PR has issues or doesn't do what ONCY says? Given the big pharma interest that seems unlikely...but I have noticed that even the long time bulls here trim their positions as the stock rises...if really big things are in the offing...why would you do that? Are there any bears or shorts on this board....make your case please??
Bullboard Posts